375
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma

, , , , , , , , & show all
Pages 2312-2318 | Received 12 Sep 2013, Accepted 06 Jan 2014, Published online: 07 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (15)

Thomas Spanberger. (2020) Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma. memo - Magazine of European Medical Oncology 13:1, pages 55-59.
Crossref
Hugo J.A. Adams & Thomas C. Kwee. (2019) Proportion of false-positive follow-up FDG-PET scans in lymphoma: systematic review and meta-analysis. Critical Reviews in Oncology/Hematology.
Crossref
Hugo J.A. Adams & Thomas C. Kwee. (2019) Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed. Journal of Clinical Oncology 37:6, pages 525-526.
Crossref
Ghulam Rehman Mohyuddin, Ashley Elizabeth Clark, John Roller, Leyla Shune, Tara Lin, Neil Dunavin, Ajoy Dias, Siddhartha Ganguly, Sunil Abhyankar, Joseph McGuirk & Anurag Singh. (2018) Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience. Hematology/Oncology and Stem Cell Therapy 11:3, pages 135-141.
Crossref
Susan M. Hiniker & Richard T. Hoppe. (2017) Post-treatment surveillance imaging in lymphoma. Seminars in Oncology 44:5, pages 310-322.
Crossref
Jonathon B. Cohen, Madhusmita Behera, Carrie A. Thompson & Christopher R. Flowers. (2017) Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Blood 129:5, pages 561-564.
Crossref
Shu-Juan Zhou, Yong-Yong Ma, Yu Zhang, Sheng Luo, Li-Yuan Tang, Yi Chen, Lan Sun & Kang Yu. (2016) Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma. Annals of Hematology 96:2, pages 237-243.
Crossref
Gunjan L. Shah & Craig H. Moskowitz. (2016) Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1215-1228.
Crossref
Narendranath Epperla, Namrata Shah, Mehdi Hamadani, Kristin Richardson, Jonathan T. Kapke, Asmita Patel, Sravanthi P. Teegavarapu, George Carrum, Parameswaran N. Hari, Sai R. Pingali, Reem Karmali & Timothy S. Fenske. (2016) Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 16:12, pages 672-678.
Crossref
Sughosh Dhakal, James E. Bates, Carla Casulo, Jonathan W. Friedberg, Michael W. Becker, Jane L. Liesveld & Louis S. Constine. (2016) Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse. International Journal of Radiation Oncology*Biology*Physics 96:2, pages 372-378.
Crossref
Michael Spencer Chapman, Shamzah Araf & Matthew Smith. (2016) Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation. Journal of Clinical Pathology 69:3, pages 275-276.
Crossref
James O. Armitage & Julie M. Vose. (2015) To Surveil or Not to Surveil. Journal of Clinical Oncology 33:34, pages 3983-3984.
Crossref
Jonathon B Cohen, David M Kurtz, Ashley D Staton & Christopher R Flowers. (2015) Next-generation surveillance strategies for patients with lymphoma. Future Oncology 11:13, pages 1977-1991.
Crossref
Hugo J. A. Adams, Rutger A. J. Nievelstein & Thomas C. Kwee. (2015) Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. British Journal of Haematology 170:2, pages 185-191.
Crossref
Susan M. Hiniker, Erqi L. Pollom, Michael S. Khodadoust, Margaret M. Kozak, Guofan Xu, Andrew Quon, Ranjana H. Advani & Richard T. Hoppe. (2015) Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology*Biology*Physics 92:1, pages 99-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.